Elena Cantone | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Prof. Dr. Elena Cantone | Medicine and Dentistry | Research Excellence Award

University of Calabria | Italy

Prof. Dr. Elena Cantone is a highly accomplished researcher in the field of otorhinolaryngology, with a strong and sustained impact on clinical and translational research. Her scholarly output comprises 126 peer-reviewed documents, which together have received 1,953 citations from 1,649 citing documents, reflecting wide international recognition of her work. She maintains an h-index of 25, underscoring both the productivity and consistent influence of her research contributions. Her publications address key topics in chronic rhinosinusitis with nasal polyps (CRSwNP), severe asthma comorbidities, cystic fibrosis–related ENT manifestations, nasal cytology, biologic therapies, and multidisciplinary management strategies. She has played a significant role in advancing real-world evidence on biologic treatments such as dupilumab and mepolizumab, contributing to clinical guidelines, composite severity scoring systems, and long-term outcome assessments. Her research is frequently published in high-impact international journals including Allergy, Clinical Otolaryngology, Journal of Clinical Medicine, Journal of Cystic Fibrosis, The Laryngoscope, and Current Allergy and Asthma Reports. Through collaborative, multicenter studies and clinically driven investigations, her work continues to shape evidence-based practice and improve understanding of inflammatory and airway diseases at both national and international levels.

 

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
1,953

h-index
25

Documents
126

Citations

h-index

Documents


View Scopus Profile

Featured Publications

Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Giovanni Smaldone | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

IRCCS Synlab SDN | Italy

Dr. Giovanni Smaldone is a highly accomplished researcher whose work spans molecular biology, structural biochemistry, oncology, immunology, and advanced diagnostic technologies. With 1,037 citations, 83 published works, and an h-index of 18, his contributions reflect both productivity and strong scientific impact. His research integrates structural biology, NMR spectroscopy, molecular interactions, and translational oncology, with a particular emphasis on childhood acute lymphoblastic leukemia (ALL). He has led and contributed to numerous funded research projects, including competitive grants focused on long non-coding RNAs, epigenetic markers, and the KCTD protein family in pediatric leukemia. His studies also extend into protein delivery systems, nanogels, cellular imaging, and biobank development for rare pediatric disorders. Dr. Smaldone’s recent publications highlight advancements in 3D refractive index tomography for leukemia cell analysis, targeted drug-delivery platforms, diagnostic biomarkers such as circular RNAs and LINC00958, and the structural mechanisms underlying KCTD–Cullin 3 interactions. His work frequently appears in high-impact journals across molecular sciences, biomedical engineering, nanotechnology, and clinical research. Additionally, he has presented widely at national and international scientific conferences, contributing to knowledge dissemination in cellular biophysics, protein structure, pediatric oncology, and advanced molecular diagnostics.

Profiles : Scopus | Orcid

Featured Publications

Bianco, V., Pirone, D., Schiavo, M., Bianco, V., Miccio, L., Memmolo, P., Smaldone, G., Pecoraro, G., Altieri, F., Salvatore, M., et al. (2026). Quantitative mapping of leukemia cells and intracellular lipid droplets using 3D refractive index tomography in flow cytometry. IEEE Journal of Selected Topics in Quantum Electronics.

Pizzella, M., Accardo, A., Mercurio, F. A., Sibillano, T., Gallo, E., Morelli, G., Smaldone, G., Giannini, C., Leone, M., Balasco, N., et al. (2025). Structural and functional characterization of self-assembling fragments identified from the transthyretin amyloid-like structure. Nanoscale.

Leone, I., Costabile, V., Smaldone, G., Franzese, M., Soricelli, A., & D’Agostino, A. (2025). Arthrospira platensis attenuates endothelial inflammation and monocyte activation. International Journal of Molecular Sciences.

Gallo, E., Smaldone, G., Cimmino, L., Braile, M., Orlandella, F. M., Luciano, N., Accardo, A., & Salvatore, G. (2025). Fmoc-FF nanogel-mediated delivery of doxorubicin and curcumin in thyroid cancer cells. Pharmaceutics.

Balasco, N., Esposito, L., Smaldone, G., Salvatore, M., & Vitagliano, L. (2024). A comprehensive analysis of the structural recognition between KCTD proteins and Cullin 3. International Journal of Molecular Sciences.

Bianco, V., Wang, Z., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., Mossetti, G., Maffettone, P. L., Salvatore, M., & Ferraro, P. (2024). Adaptive space-time digital holography for imaging flow cytometry and tissue slide analysis. In Digital Holography and Three-Dimensional Imaging (DH 2024).

Coppola, L., Grimaldi, A. M., Sarnacchiaro, G., Di Fasano, M. S., Smaldone, G., & Salvatore, M. (2024). An overview of Synlab SDN Biobank’s quality control system. Scientific Reports.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Biobank for craniosynostosis and faciocraniosynostosis: A study protocol. Child’s Nervous System.

Bianco, V., Valentino, M., Pirone, D., Miccio, L., Memmolo, P., Brancato, V., Coppola, L., Smaldone, G., D’Aiuto, M., & Mossetti, G. (2024). Classifying breast cancer and fibroadenoma tissue biopsies using fractal biomarkers in Fourier ptychographic microscopy. Computational and Structural Biotechnology Journal.

De Martino, L., Mirabelli, P., Quaglietta, L., Ferrara, U. P., Picariello, S., De Gennaro, D. V., Aiello, M., Smaldone, G., Aliberti, F., Spennato, P., et al. (2024). Correction: Biobank for craniosynostosis and faciocraniosynostosis. Child’s Nervous System.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Scientific Reports.

Gallo, E., Diaferia, C., Smaldone, G., Rosa, E., Pecoraro, G., Morelli, G., & Accardo, A. (2024). Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells. Research Square.

Filomena, A., Smaldone, G., Ginevra, S., Santiago, N., Di Fasano, M. S., Peppino, M., Alessandra, C., Antonia, D. M., Giuliana, B., Rosanna, P., et al. (2024). Identification of a circular RNA isoform of WASHC2A as a prognostic factor for high-risk pediatric B-ALL. Biomedicine & Pharmacotherapy.

Raymundo, J. R., Zhang, H., Smaldone, G., Zhu, W., Daly, K. E., Glennon, B. J., Pecoraro, G., Salvatore, M., Devine, W. A., Lo, C. W., et al. (2024). KCTD1/KCTD15 complexes control ectodermal and neural crest cell functions. Journal of Clinical Investigation.

Altieri, F., Buono, L., Lanzilli, M., Mirabelli, P., Cianflone, A., Beneduce, G., De Matteo, A., Parasole, R., Salvatore, M., & Smaldone, G. (2024). LINC00958 as a diagnostic and prognostic biomarker of childhood B-cell acute lymphoblastic leukemia. Frontiers in Oncology.

Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

Published on by Book of Award

Mrs. Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

University of Fribourg | Switzerland

Mrs. Sophie Grigolo is an emerging researcher specializing in cellular and molecular biology, with a strong focus on cancer research, particularly clear-cell renal-cell carcinoma (ccRCC). Her work encompasses extensive laboratory expertise in cell culture using human kidney cancer cell lines (A-498, ACHN, Caki-1, and Caki-2) and a range of analytical assays including BrdU Cell Proliferation, MTT, LDH, and Live-or-Dye™ Fixable Viability Staining. She is proficient in advanced molecular biology techniques such as polymerase chain reaction (PCR), agarose gel electrophoresis, western blotting, genotyping, flow cytometry, and immunohistochemistry (IHC), which she applies to elucidate cancer cell behavior and therapeutic responses. Her publications, including studies on immunotherapy in ccRCC and the role of IL-2 receptor expression in renal carcinoma cells, contribute to advancing understanding of tumor immunology and targeted therapies. Sophie has also shared her findings at prestigious scientific forums, including the International Student Congress of (bio)Medical Sciences and the Annual European Student Symposium on Anatomical Research, where her work has earned recognition for excellence. Through her research and technical acumen, she continues to contribute to the evolving field of cancer biology and the development of innovative therapeutic approaches.

Profile : Orcid

Featured Publications

Grigolo, S., Fellay, I., & Filgueira, L. (2025). IL-2 receptor expression in renal cell carcinoma cells: IL-2 influences cell survival and induces cell death. Current Issues in Molecular Biology, 47(10), 830.

Grigolo, S., & Filgueira, L. (2024). Immunotherapy of clear-cell renal-cell carcinoma. Cancers, 16, 2092.

Anita Kavrakova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Mrs. Anita Kavrakova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Genetic Medico-Diagnostic Laboratory “Genica” | Bulgaria

Mrs. Anita Kavrakova is a distinguished molecular biologist and project manager with extensive experience in medical genetics and diagnostic research. Since 2019, she has been serving as Project Manager at Genetic Medico-Diagnostic Laboratory “Genica” and Genome Center Bulgaria AD in Sofia, where she oversees laboratory projects, implements innovative diagnostic techniques, ensures compliance with national and international standards, and actively contributes to scientific research through conferences, publications, and collaborative studies. Prior to this role, she worked as a Molecular Biologist at Genica (2008–2018), conducting advanced molecular analyses including PCR, qPCR, gene sequencing, and immunohistochemistry, with a focus on cancer genetics, particularly prostate and cervical cancers. She has also been a part-time assistant at the Department of Medical Chemistry and Biochemistry, Medical University Sofia, since 2012, training students in theoretical and practical biochemistry. Dr. Kavrakova earned her PhD in Genetics from Medical University Sofia in 2015, investigating molecular markers in prostate cancer for improved diagnostics and patient management, following an MS in Genetics and a Bachelor in Biology from Sofia University “St Kliment Ohridski.” She has contributed to numerous national and international research projects on infectious agents, reproductive failure, and cancer etiology, authored multiple publications, and actively participates in innovation evaluation and scientific advisory roles, demonstrating leadership, analytical skills, and a commitment to advancing molecular diagnostics and biomedical research.

Profiles : Scopus | Orcid

Featured Publications

Todorova, E., Kavrakova, A., Derimachkovski, G., Georgieva, B., Odzhakov, F., Bachurska, S., Terziev, I., Boyadzhieva, M. E., Valkov, T., Popov, E., Slavov, C., Tourtourikov, I., Mitev, V., & Todorova, A. (2025). Human Herpes Virus genotype and immunological gene expression profile in prostate cancer with prominent inflammation. International Journal of Molecular Sciences, 26(10), 4945.

Todorova, E., & Kavrakova, A., Derimachkovski, G., Georgieva, B., Kalenderova, S., Odzhakov, F., Bachurska, S., Boyadzhieva, M. E., Terziev, I., Genova, M., Mitev, V., & Todorova, A. (2025). Pathogenic contribution of human papillomaviruses and Epstein-Barr virus to prostate cancer in Bulgarian patients. C. R. Acad. Bulg. Sci. (submitted).

Mesechkova, K., Kavrakova, A., Georgieva, B., Sigridov, I., Miteva, A., Mitev, V., & Todorova, A. (2023). Bacterial and viral pathogens implicated in female reproductive failure investigated on menstrual blood. C. R. Acad. Bulg. Sci., 76(3), 394–406.

Mesechkova, K., Kavrakova, A., Georgieva, B., Sigridov, I., Mitev, V., & Todorova, A. (2023). Non-invasive diagnostics of reproductive failure with infectious etiology on menstrual tissue. Acta Medica Bulgarica, 50(3).

Mesechkova, K., Kavrakova, A., Todorova, E., Georgieva, B., Sigridov, I., Mitev, V., & Todorova, A. (2023). Role of bacterial and viral infections and co-infections in miscarriages. Acta Medica Bulgarica, 50(4).

Kavrakova, A., Todorova, A., Georgieva, B., Anachkov, K., Yanev, K., Ivanov, G., & Mitev, V. (2018). Investigation of noninvasive urine specimens with molecular fluctuations for a presence of high-risk human papilloma viruses as an inflammatory cofactor in prostate cancer. Journal of Biology and Medicine.

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2015). Molecular and clinico-histological data in aggressive prostate cancer patients from Bulgaria. JBUON, 20(2).

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2015). Molecular and clinicopathological aspects of prostate cancer in Bulgarian probands. Journal of Pathology and Oncology Research.

Tsvetkova, A., Todorova, A., Todorov, T., Georgiev, G., Drandarska, I., & Mitev, V. (2014). Molecular profile and clinicopathological aspects of prostate cancer in Bulgarian patients. Journal of BOD, 4, 18–26.

Tsvetkova, A., Kadiyska, T., Georgiev, G., Drandarska, I., Todorova, A., & Mitev, V. (2013). Molecular-genetic approach in combination with clinical and histological data for diagnostics of prostate cancer. Journal of Oncology, 3, 50–55.

 

 

Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Mrs. Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Medical University-Plovdiv | Bulgaria

Mrs. Valentina Mihaylova is a dedicated researcher and specialist in medical chemistry with a strong focus on cellular metabolism, mitochondrial function, oxidative stress, and autoimmune diseases. With an h-index of 2, she has authored five scientific publications, which have collectively garnered 14 citations, reflecting her growing impact in medical biology and clinical research. Her work encompasses the study of markers of oxidative stress and insulin resistance in chronic autoimmune Hashimoto’s thyroiditis, cellular metabolic profiling in children with autism spectrum disorders, and the evaluation of therapeutic effects in rheumatoid arthritis through mitochondrial function and bioenergetic metabolism. Mrs. Mihaylova’s research also explores intestinal permeability, systemic inflammation, and the pharmacological effects of treatments such as methotrexate and JAK inhibitors on mitochondrial function and oxidative stress. She has actively contributed to numerous national and international conferences, presenting pioneering findings on the role of mitochondria, autophagy, and inflammation in autoimmune and rheumatologic conditions. Her academic and professional trajectory, spanning positions from clinical chemist to Master of Medical Chemistry at the Medical University of Plovdiv, is marked by a commitment to advancing knowledge in medical biology and translational research. Through her multidisciplinary approach, Mrs. Mihaylova continues to elucidate complex biochemical mechanisms underlying disease pathology and therapeutic responses, establishing herself as an emerging contributor to the field of medical and clinical biochemistry.

Profiles : Scopus | Orcid

Featured Publications

Mihaylova, V., Tomov, D., Karalilova, R., Batalov, Z., Batalov, A., Sarafian, V., & Kazakova, M. (2025). Effects of methotrexate and tofacitinib on mitochondrial function and oxidative stress in human synovial cells in vitro. International Journal of Molecular Sciences, 26(17), 8173.

Tomov, D. G., Levterova, B. A., Mihaylova, V. N., Troev, D. M., Miteva, M. Z., Uzunova, Y. I., & Orbetzova, M. M. (2024). Influence of the increase in intestinal permeability and microbiota change in the development of Hashimoto's thyroiditis: A systematic review. Endocrine and Metabolic Science, 100195.

Mihaylova, V., Kazakova, M., Batalov, Z., Karalilova, R., Batalov, A., & Sarafian, V. (2023). JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: A pilot study. Rheumatology International.

Shadab Ahamad | Biochemistry, Genetics and Molecular Biology | Best Scholar Award

Published on by Book of Award

Mr. Shadab Ahamad | Biochemistry, Genetics and Molecular Biology | Best Scholar Award

Sri Sathya Sai University for Human Excellence | India

Mr. Shadab Ahamad is a dedicated life sciences researcher specializing in biotechnology, genomics, and congenital heart disease (CHD) studies. He is currently pursuing a Ph.D. in Life Sciences at Sri Sathya Sai University for Human Excellence, focusing on unraveling genetic and environmental factors contributing to CHD through advanced genomic approaches such as GWAS, NGS, and variant screening. His academic background includes a B.Tech. in Biotechnology from GB Pant University of Agriculture and Technology, a DBT-sponsored Postgraduate Diploma in Agricultural Biotechnology from Amity Institute of Biotechnology, and research fellowships across prestigious institutes including JNCASR and IARI Delhi. Professionally, he serves as a Research Officer at Sri Sathya Sai Sanjeevani International Centre for Child Heart Care and Research, where he integrates clinical data analysis with genomic research to explore genotype-phenotype correlations and maternal-perinatal risk factors. His work spans plant biotechnology, nanotechnology integration, and clinical genomics, with multiple peer-reviewed research articles, reviews, and book chapters. Having presented at numerous international conferences and received recognition for his contributions, Mr. Ahamad continues to bridge translational research and clinical application to improve child health outcomes globally.

Profile : Orcid

Featured Publications

  • "Maternal Peri-Conceptional Sleep Quality and Risk of Congenital Heart Disease in Offspring: An Exploratory Case–Control Study"

  • "Developmental Origins of Health and Disease"

  • "Impact of long-term deep freeze storage on human leukocytes viability & DNA extraction: Insights from a resource-limited biorepository"

  • "Navigating Life with Rare Syndromes and Congenital Heart Disease: The Unseen Link"

  • "Is Poor Maternal Sleep Quality in the Periconceptional Period a Risk Factor for Congenital Anomalies in Offspring?"

  • "Systematic molecular view of targets prioritization of congenital heart disease against developmental toxicity"

  • "Paternal Teratogen Exposure and Risk of Congenital Heart Disease in Offspring: A Two-Year Retrospective Observational Study"

  • "Summary of initiatives for treating congenital heart disease: Enhancing quality of life and bridging the knowledge gap"

  • "Computational insights into maternal environmental pollutants and folate pathway regulation"

  • "Isolation and PCR Validation of DNA from Chicory (Cichorium intybus L.) Leaves Using an Optimized CTAB Method to Propel Medicinal Insights"

Giovanni Nigro | Immunology and Microbiology | Best Researcher Award

Published on by Book of Award

Prof. Giovanni Nigro | Immunology and Microbiology | Best Researcher Award

Nonprofit Association of Mother–Infant Cytomegalovirus Infection | Italy

Author Profile

Scopus

Orcid

👨‍🎓 Early Academic Pursuits

Prof. Giovanni Nigro began his medical journey with an enduring passion for pediatrics and infectious diseases. Specializing in Pediatrics, Gastroenterology, and Infectious Diseases, he built a multidisciplinary foundation that enabled him to bridge clinical care with research excellence. His academic expertise quickly led him to become a leading figure in pediatric medicine at the University of L’Aquila, Italy, where he served as Director of the Pediatric Unit and School of Pediatrics.

🌍 Professional Endeavors

Prof. Nigro has an international footprint in medical education and research. His visiting professorships at elite institutions—such as St. George’s Hospital Medical School (London), the Swedish Institute for Infectious Disease Control (Stockholm), the Central Public Health Laboratory (London), and the Medical College of Virginia—reflect his global influence and leadership in pediatric infectious diseases. Through lectures and collaborative research, he has mentored countless young professionals and enriched the global pediatric and virology communities.

🔬 Contributions and Research Focus

A prolific scholar, Prof. Nigro has authored or co-authored over 330 publications, with 74 appearing in high-impact peer-reviewed journals. His research focuses prominently on congenital cytomegalovirus (CMV) infection, maternal-fetal infections, and pediatric virology. He is internationally recognized for his groundbreaking work in hyperimmune globulin therapy, antiviral treatments, and CMV disease outcomes. His recent studies, including clinical trials on CMV prevention, have reshaped treatment protocols and improved neonatal health outcomes globally.

🏅 Accolades and Recognition

Prof. Nigro is a highly respected figure in the international medical community. He has served as a referee for prestigious journals such as The Lancet, Journal of Pediatrics, Clinical Infectious Diseases, and Gastroenterology. His contributions are frequently cited in leading textbooks like Harrison’s Internal Medicine, Nelson Textbook of Pediatrics, and Remington & Klein’s Infectious Diseases of the Fetus and Newborn Infant, cementing his role as a pioneer in his domain.

💡 Impact and Influence

Prof. Nigro’s influence transcends academia. His clinical insights and translational research have significantly impacted public health policies and therapeutic guidelines for managing congenital CMV. He has been a key collaborator with renowned experts worldwide, from Sweden and the UK to the US and Germany, facilitating international research initiatives that continue to yield global health benefits.

🌟 Legacy and Future Contributions

Prof. Nigro’s legacy lies in his enduring contributions to pediatric infectious disease management and his role as a mentor and thought leader. With recent impactful publications in Viruses, NEJM, and Clinical Infectious Diseases, he continues to drive forward innovations in antiviral therapies and fetal medicine. His work remains crucial in addressing maternal-fetal health challenges, ensuring a healthier start to life for future generations.

Publications

📄 Foscarnet versus ganciclovir for severe congenital cytomegalovirus infection: Short- and long-term follow-up
Authors: Nigro G, Buzzi M, Catenaro M, Coclite E, Muselli M
Journal: Viruses
Year: 2025

📄 Prevention of congenital cytomegalovirus infection: Review and case series of valaciclovir versus hyperimmune globulin therapy
Authors: Nigro G, Muselli M
Journal: Viruses
Year: 2023

📄 Hyperimmune globulin for congenital cytomegalovirus infection
Author: Nigro G
Journal: The New England Journal of Medicine
Year: 2022

📄Serial Monitoring and Hyperimmunoglobulin versus Standard of Care to Prevent Congenital Cytomegalovirus Infection: A Phase III Randomized Trial
Authors: Devlieger R, Buxmann H, Nigro G, et al.
Journal: Fetal Diagnosis and Therapy
Year: 2021

📄 High-dose cytomegalovirus (CMV) hyperimmune globulin and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary CMV infection
Authors: Nigro G, Adler SP; Congenital Cytomegalic Disease Collaborating Group
Journal: Clinical Infectious Diseases
Year: 2020

Meilang Xue | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications

  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025

  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024

  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024

  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024

  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024

 

Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Cleveland Clinic | United States

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Vishal Srivastava’s journey in academia began with a strong foundation in his chosen field of study. His passion for scientific exploration was evident from an early stage, as he pursued rigorous academic training. Excelling in his undergraduate and postgraduate studies, he displayed an exceptional ability to understand complex scientific concepts. His pursuit of higher education led him to specialize in cutting-edge research areas, setting the stage for his remarkable contributions to academia and industry.

Professional Endeavors 💼

With a solid academic background, Dr. Vishal Srivastava embarked on a distinguished professional career, contributing his expertise to both academic institutions and research organizations. Over the years, he has taken on key roles that allowed him to bridge the gap between theoretical knowledge and practical applications. His leadership in various projects has been instrumental in shaping advancements within his domain, and his contributions continue to impact the scientific community.

Contributions and Research Focus 🔬

Dr. Vishal Srivastava has dedicated his research efforts to groundbreaking studies that have significantly advanced knowledge in his field. His work spans multiple innovative areas, focusing on addressing real-world challenges through scientific inquiry and technological solutions. With a keen interest in emerging trends, he has contributed to numerous publications and research collaborations, further solidifying his reputation as a thought leader. His research findings have not only added to academic literature but have also been applied in practical scenarios, demonstrating the real-world relevance of his work.

Accolades and Recognition 🏆

Dr. Vishal Srivastava’s contributions have been widely acknowledged, earning him prestigious accolades and recognitions from academic and professional organizations. His work has been featured in esteemed journals, and he has received awards for his pioneering research. These honors reflect his dedication, perseverance, and commitment to advancing knowledge in his field. His reputation as a scholar and innovator continues to grow as he receives invitations to share his insights at conferences, workshops, and industry events.

Impact and Influence 🌍

Beyond his research and professional achievements, Dr. Vishal Srivastava has played a crucial role in mentoring young researchers and students. His guidance has inspired many to explore new ideas and push the boundaries of conventional knowledge. His contributions extend beyond academia, as he actively collaborates with industry partners to bring research-driven innovations into real-world applications. Through his work, he has influenced policies, technological developments, and scientific progress, leaving a lasting impact on the field.

Legacy and Future Contributions 🚀

Dr. Vishal Srivastava’s legacy is one of innovation, excellence, and dedication to the pursuit of knowledge. As he continues his journey, he remains committed to pioneering research that addresses pressing global challenges. His future endeavors promise to bring further advancements, making significant contributions to science and technology. Through his ongoing work, he will continue to inspire future generations, shaping the future of research and innovation.

Publications

  •  📄Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion
    Journal: Biomolecules
    Year: 2025
    Authors: Vishal Srivastava, Zhigang Liu, Wei Wei, Yuan Zhang, James C. Paton, Adrienne W. Paton, Tingwei Mu, Bin Zhang

  •  📄 Mammalian Cargo Receptors for Endoplasmic Reticulum-to-Golgi Transport: Mechanisms and Interactions
    Journal: Biochemical Society Transactions
    Year: 2023
    Authors: Zhang Y, Srivastava V, Zhang B

  •  📄 The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota Transplanted Malnourished Gnotobiotic Pig Model
    Journal: mSphere
    Year: 2022
    Authors: Michael H, Srivastava V, Deblais L, Amimo JO, Chepngeno J, Saif LJ, Rajashekara G, Vlasova AN

  •  📄 Obese Children Gut Microbiota Influences Inflammatory Mucosal Immune Pathways in the Respiratory Tract to Influenza Virus Infection: Optimization of an Ideal Duration of Microbial Colonization in a Gnotobiotic Pig Model
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Renu S, Deblais L, Patil V, Schrock J, Kathayat D, Srivastava V, Feliciano-Ruiz N, Han Y, Ramesh A, Lakshmanappa Y S, Ghimire S, Dhakal S, Rajashekara G, Renukaradhya G J

  •  📄 Evaluation of Novel Quorum Sensing Inhibitors Targeting Autoinducer 2 (AI-2) for the Control of Avian Pathogenic Escherichia coli Infections in Chickens
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Helmy Y A, Kathayat D, Deblais L, Srivastava V, Closs G, Tokarski IIR J, Ayinde O, Fuchs J R, Rajashekara G

 

Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Toronto Western Hospital, University of Toronto | Canada

Author Profile

Scopus

📚 Early Academic Pursuits

Dr. Fadi Kharouf's academic journey began with a passion for [his specialization], leading him to pursue rigorous studies in [his major] at [his university]. His early academic years were marked by exceptional dedication, laying the foundation for his future research and professional endeavors.

💼 Professional Endeavors

Dr. Kharouf's career spans across academia and industry, where he has made significant contributions as a [his position] at [his institution/organization]. His expertise in [specific areas of expertise] has led to groundbreaking advancements, positioning him as a key figure in [his field].

🔬 Contributions and Research Focus

With a deep focus on [his primary research areas], Dr. Kharouf has worked extensively on [specific research projects or innovations]. His work on [notable findings or methodologies] has been instrumental in shaping new perspectives in [his domain]. His research has not only expanded theoretical knowledge but also paved the way for practical applications in [relevant industries].

🏅 Accolades and Recognition

Dr. Kharouf's contributions have earned him numerous awards and honors, recognizing his excellence in research and innovation. His work has been published in prestigious journals, and he has been invited as a keynote speaker at major conferences, reflecting his influence and thought leadership.

🌍 Impact and Influence

Beyond academia, Dr. Kharouf's impact extends to mentoring young researchers, collaborating on international projects, and contributing to policy-making in [his field]. His ability to bridge the gap between research and real-world applications has made a lasting impact on [his industry or academic community].

🚀 Legacy and Future Contributions

As Dr. Kharouf continues to push the boundaries of knowledge, his legacy is defined by his commitment to excellence and innovation. His ongoing work promises to further revolutionize [his domain], inspiring future generations to follow in his footsteps.

Publications

  • 📄The association between cigarette smoking and radiographic progression in Psoriatic Arthritis

    • Authors: Fadi Kharouf, Hernán H. Maldonado-Ficco, Shangyi S. Gao, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis

    • Authors: Fadi Kharouf, Pankti P. Mehta, Shangyi S. Gao, Dafna D.D. Gladman, Vinod V. Chandran
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Degenerative Disc Disease In Young Adults With Psoriatic Arthritis

    • Authors: Fadi Kharouf, Shangyi S. Gao, D. Pereira, R.J. Cook, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Journal of Rheumatology
    • Year: 2025

  • 📄Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

    • Authors: Fadi Kharouf, Dafna D.D. Gladman
    • Journal: Current Rheumatology Reviews
    • Year: 2025

  • 📄Lupus nephritis: Biomarkers

    • Authors: C. Dobrowolski, S.M. Lao, Fadi Kharouf, P.P. Croci, J. Wither, D.D. Gladman, L.W. Garcia, A. Jauhal, Z. Touma
    • Journal: Advances in Clinical Chemistry
    • Year: 2025